These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37234934)

  • 41. A pyrosequencing protocol for rapid identification of SARS-CoV-2 variants.
    Allen RA; Williams CL; Penrod Y; McCloskey C; Carpenter-Azevedo K; Huard RC; King E; Terence Dunn S
    J Med Virol; 2022 Aug; 94(8):3661-3668. PubMed ID: 35416308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of
    Jhun H; Park HY; Hisham Y; Song CS; Kim S
    Immune Netw; 2021 Oct; 21(5):e32. PubMed ID: 34796036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 in early 2023: Structure, replication mechanism, variants of SARS-CoV-2, diagnostic tests, and vaccine & drug development studies.
    Polatoğlu I; Oncu-Oner T; Dalman I; Ozdogan S
    MedComm (2020); 2023 Apr; 4(2):e228. PubMed ID: 37041762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding.
    Popovic M
    BioTech (Basel); 2022 Oct; 11(4):. PubMed ID: 36278557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.
    Yang L; Li J; Guo S; Hou C; Liao C; Shi L; Ma X; Jiang S; Zheng B; Fang Y; Ye L; He X
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants.
    Goc A; Niedzwiecki A; Ivanov V; Ivanova S; Rath M
    Eur J Microbiol Immunol (Bp); 2022 Feb; 11(4):87-94. PubMed ID: 35060921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel vaccine based on SARS-CoV-2 CD4
    Palatnik-de-Sousa I; Wallace ZS; Cavalcante SC; Ribeiro MPF; Silva JABM; Cavalcante RC; Scheuermann RH; Palatnik-de-Sousa CB
    Sci Rep; 2022 Oct; 12(1):16731. PubMed ID: 36202985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done.
    Luo R; Delaunay-Moisan A; Timmis K; Danchin A
    Environ Microbiol; 2021 May; 23(5):2339-2363. PubMed ID: 33769683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thermodynamic measures of cancer: Gibbs free energy and entropy of protein-protein interactions.
    Rietman EA; Platig J; Tuszynski JA; Lakka Klement G
    J Biol Phys; 2016 Jun; 42(3):339-50. PubMed ID: 27012959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.
    Spratt AN; Kannan SR; Woods LT; Weisman GA; Quinn TP; Lorson CL; Sönnerborg A; Byrareddy SN; Singh K
    Comput Struct Biotechnol J; 2021; 19():3799-3809. PubMed ID: 34188776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization and validation of RT-LAMP assay for diagnosis of SARS-CoV2 including the globally dominant Delta variant.
    Jamwal VL; Kumar N; Bhat R; Jamwal PS; Singh K; Dogra S; Kulkarni A; Bhadra B; Shukla MR; Saran S; Dasgupta S; Vishwakarma RA; Gandhi SG
    Virol J; 2021 Aug; 18(1):178. PubMed ID: 34461941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Evolution and Biology of SARS-CoV-2 Variants.
    Telenti A; Hodcroft EB; Robertson DL
    Cold Spring Harb Perspect Med; 2022 May; 12(5):. PubMed ID: 35444005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
    Ridgway H; Ntallis C; Chasapis CT; Kelaidonis K; Matsoukas MT; Plotas P; Apostolopoulos V; Moore G; Tsiodras S; Paraskevis D; Mavromoustakos T; Matsoukas JM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851526
    [No Abstract]   [Full Text] [Related]  

  • 56. An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants.
    Chi X; Zhang X; Pan S; Yu Y; Shi Y; Lin T; Duan H; Liu X; Chen W; Yang X; Chen L; Dong X; Ren L; Ding Q; Wang J; Yang W
    Signal Transduct Target Ther; 2022 Feb; 7(1):44. PubMed ID: 35140196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.
    Castonguay N; Zhang W; Langlois MA
    Front Microbiol; 2021; 12():676314. PubMed ID: 34267735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.
    Head RJ; Lumbers ER; Jarrott B; Tretter F; Smith G; Pringle KG; Islam S; Martin JH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00922. PubMed ID: 35106955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo.
    Diaz-Meco MT; Municio MM; Sanchez P; Lozano J; Moscat J
    Mol Cell Biol; 1996 Jan; 16(1):105-14. PubMed ID: 8524286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.